Summary
We examined the state of bacteria detected from patients during brain hypothermia and the pharmacokinetics of antibiotics administered for antibiotic prophylaxis. Samples including blood were collected from patients who underwent brain hypothermia at the Nihon University Itabashi Hospital Emergency and Critical Care Center, and the type of bacteria and interval until detection were investigated using these samples. Simultaneously, we measured concentrations of antibiotics administered for antibiotic prophylaxis [cefmetazole (CMZ), flomoxef (FMOX), cefoperazone/sulbactam (CPZ/SBT), aspoxicillin (ASPC), arbekacin (ABK), amikacin (AMK)] and compared the half-lives of these agents during the cooling stage or during the cooling and rewarming stages. Bacteria such as methicillin-resistant staphylococcus aureus (MRSA), Pseudomonas aeruginosa, and Candida were mainly detected. The mean interval until the bacterial detection was 4.4 days after rewarming was started. Of the administered antibiotics, half-lives of agents that are mainly eliminated via kidney excretion (CMZ, FMOX, SBT, ABK) did not differ during the cooling and rewarming stages. However, for two patients receiving CPZ, an agent metabolized in the liver, the half-life of CPZ was markedly prolonged during hypothermia in one patient with liver dysfunction, whereas there was no prolongation in the other patient. The results of this study suggest that the types of bacteria detected are similar to those in other patients hospitalized in the intensive care unit. With respect to the pharmacokinetics of antibiotics, the half-life of CPZ was prolonged in one patient during the cooling stage, suggesting that the drug-metabolizing capacity in the liver parenchyma may be reduced during hypothermia. Therefore, antibiotics that are metabolized in the liver should be administered cautiously.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Hayashi N (1995) The cerebral hypothermia treatment. Sougouigakusha, Tokyo, pp 53–59
Kawata K, Sakaguchi M, Higashizawa T (1997) The pharmacokinetics of lidocaine and its metabolite (MEGX) in hypothermic state. Jpn J Ther Drug Monit 14:311–317
Sirai K, Tanjyou K, Hayashi N (1998) Nutrional support on hypothermia. Intensive Grit Care Med 12:1369–1370
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer-Verlag Tokyo
About this paper
Cite this paper
Kaburagi, M. et al. (2000). Bacteria Detected and the Pharmacokinetics of Antibiotics During Brain Hypothermia. In: Hayashi, N. (eds) Brain Hypothermia. Springer, Tokyo. https://doi.org/10.1007/978-4-431-66882-4_12
Download citation
DOI: https://doi.org/10.1007/978-4-431-66882-4_12
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-70277-1
Online ISBN: 978-4-431-66882-4
eBook Packages: Springer Book Archive